Evidence map›Paper›PMID 41731147›Full record

ArticleNature immunology2026

The immunometabolic topography of cellular organization and bacterial control in tuberculosis granulomas.

Erin F McCaffrey, Alea C Delmastro, Isobel Fitzhugh, Jolene S Ranek, Sarah Douglas, Joshua M Peters, Christine Camacho Fullaway, Marc Bosse, Candace C Liu, Craig Gillen and 24 more

Abstract read
In one paragraph

Article in Nature immunology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 22 papers.

0numbers the graph read from it
0cells of the map it votes in
22citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

22 citing papers in PubMed.

  1. Review
  2. Review
  3. Therapeutic remodeling of the tuberculosis granuloma with 1-methyl-D-tryptophan enhances CD8Proceedings of the National Academy of Sciences of the United States of America · 2026
    Article
  4. Review
  5. Article
  6. Review
  7. Article
  8. Article
  9. Article
  10. HowVaccines · 2026
    Review
  11. Article
  12. Article
  13. Review
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

34 authors.

Erin F McCaffrey *Department of Pathology, Stanford University School of Medicine, Stanford, CA, USA. erin.mccaffrey@nih.gov.ORCID http://orcid.org/0000-0001-7241-1798
Alea C Delmastro *Department of Pathology, Stanford University School of Medicine, Stanford, CA, USA.ORCID http://orcid.org/0000-0002-7959-3165
Isobel FitzhughThe Department of Biomedical Sciences and Technology, AdventHealth University, Orlando, FL, USA.
Jolene S RanekDepartment of Pathology, Stanford University School of Medicine, Stanford, CA, USA.ORCID http://orcid.org/0000-0002-0701-0565
Sarah DouglasDepartment of Pathology, Stanford University School of Medicine, Stanford, CA, USA.
Joshua M PetersDepartment of Biological Engineering, MIT, Cambridge, MA, USA.
Christine Camacho FullawayDepartment of Pathology, Stanford University School of Medicine, Stanford, CA, USA.ORCID http://orcid.org/0000-0002-4924-591X
Marc BosseDepartment of Pathology, Stanford University School of Medicine, Stanford, CA, USA.ORCID http://orcid.org/0000-0003-4912-8059
Candace C LiuDepartment of Pathology, Stanford University School of Medicine, Stanford, CA, USA.
Craig GillenThe Department of Biomedical Sciences and Technology, AdventHealth University, Orlando, FL, USA.
Noah F GreenwaldDepartment of Pathology, Stanford University School of Medicine, Stanford, CA, USA.
Sarah AnzickResearch Technologies Branch, Rocky Mountain Laboratories, National Institute of Allergy and Infectious Diseases, NIH, Hamilton, MT, USA.
Craig MartensResearch Technologies Branch, Rocky Mountain Laboratories, National Institute of Allergy and Infectious Diseases, NIH, Hamilton, MT, USA.
Seth WinfreeResearch Technologies Branch, Rocky Mountain Laboratories, National Institute of Allergy and Infectious Diseases, NIH, Hamilton, MT, USA.
Yunhao BaiDepartment of Pathology, Stanford University School of Medicine, Stanford, CA, USA.
Cameron SowersDepartment of Pathology, Stanford University School of Medicine, Stanford, CA, USA.
Mako GoldstonDepartment of Pathology, Stanford University School of Medicine, Stanford, CA, USA.
Alex KongDepartment of Pathology, Stanford University School of Medicine, Stanford, CA, USA.
Potchara BoonratDepartment of Pathology, Stanford University School of Medicine, Stanford, CA, USA.
Carolyn L BigbeeDepartment of Microbiology and Molecular Genetics, School of Medicine, University of Pittsburgh, Pittsburgh, PA, USA.
Roopa VenugopalanCenter for Vaccine Research, School of Medicine, University of Pittsburgh, Pittsburgh, PA, USA.
Pauline MaielloDepartment of Microbiology and Molecular Genetics, School of Medicine, University of Pittsburgh, Pittsburgh, PA, USA.
Edwin KleinDivision of Laboratory Animal Research, University of Pittsburgh, Pittsburgh, PA, USA.
Mark A RodgersDepartment of Microbiology and Molecular Genetics, School of Medicine, University of Pittsburgh, Pittsburgh, PA, USA.
Charles A ScangaDepartment of Microbiology and Molecular Genetics, School of Medicine, University of Pittsburgh, Pittsburgh, PA, USA.ORCID http://orcid.org/0000-0003-3654-5603
Philana Ling LinCenter for Vaccine Research, School of Medicine, University of Pittsburgh, Pittsburgh, PA, USA.ORCID http://orcid.org/0000-0001-5169-3714
Sean C BendallDepartment of Pathology, Stanford University School of Medicine, Stanford, CA, USA.ORCID http://orcid.org/0000-0003-1341-2453
Denise E KirschnerDepartment of Microbiology and Immunology, University of Michigan Medical School, Ann Arbor, MI, USA.ORCID http://orcid.org/0000-0002-1053-2591
Sarah M FortuneRagon Institute of Mass General, Harvard, and MIT, Cambridge, MA, USA.ORCID http://orcid.org/0000-0001-7565-9975
Bryan D BrysonDepartment of Biological Engineering, MIT, Cambridge, MA, USA.ORCID http://orcid.org/0000-0003-1716-6712
J Russell ButlerThe Department of Biomedical Sciences and Technology, AdventHealth University, Orlando, FL, USA.
Joshua T MattilaCenter for Vaccine Research, School of Medicine, University of Pittsburgh, Pittsburgh, PA, USA.
JoAnne L FlynnDepartment of Microbiology and Molecular Genetics, School of Medicine, University of Pittsburgh, Pittsburgh, PA, USA.ORCID http://orcid.org/0000-0001-7874-8981
Michael AngeloDepartment of Pathology, Stanford University School of Medicine, Stanford, CA, USA. mangelo0@stanford.edu.ORCID http://orcid.org/0000-0003-1531-5067

Funding

Dynamics of the cellular and molecular architecture of human pulmonary TB granulomasR01AI166313 · NIAID · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI ROBERT L MODLIN · 2022 to 2026
$3.2M
Elucidating the mechanisms and consequences of MDSC-regulated immunity in TBR01AI164970 · NIAID · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI Bryan David Bryson, Joshua T. Mattila · 2022 to 2026
$2.7M
Evaluating macrophage antiviral immunity as a suppressive factor in SIV-M. tuberculosis co-infectionR21AI167710 · NIAID · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI MATTILA, JOSHUA T. · 2022 to 2023
$420k
USING DEEP MUTATIONAL SCANNING TO CHARACTERIZE TUMOR-IMMUNE INTERACTIONSK00CA264307 · NCI · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI NOAH GREENWALD · 2025 to 2026
$192k
Gravidity-dependent Mechanisms of Myeloid Cell-mediated Protection against Placental MalariaF31AI191425 · NIAID · STANFORD UNIVERSITY · PI Alea Christine Delmastro · 2025 to 2026
$86k
Comprehensive profiling of the tumor microenvironment to predict patient response to immunotherapyF99CA264307 · NCI · STANFORD UNIVERSITY · PI GREENWALD, NOAH · 2021 to 2022
$79k
Predicting response to anti-PD-1 therapy in triple negative breast cancer by comprehensive profiling of the tumor microenvironmentF31CA246880 · NCI · STANFORD UNIVERSITY · PI GREENWALD, NOAH · 2020 to 2021
$53k
NCI NIH HHS F31 CA246880NCI NIH HHS F99 CA264307NCI NIH HHS K00 CA264307NIAID NIH HHS F31 AI191425NIAID NIH HHS R01 AI164970NIAID NIH HHS R01 AI166313NIAID NIH HHS R21 AI167710U.S. Department of Health & Human Services | National Institutes of Health (NIH) AI164970U.S. Department of Health & Human Services | National Institutes of Health (NIH) AI191425U.S. Department of Health & Human Services | National Institutes of Health (NIH) CA264307U.S. Department of Health & Human Services | National Institutes of Health (NIH) R01AI164970U.S. Department of Health & Human Services | National Institutes of Health (NIH) R01AI166313Wellcome Trust
6 · The paper itself

Abstract

Despite being heavily infiltrated by immune cells, tuberculosis (TB) granulomas often subvert the host response to Mycobacterium tuberculosis (Mtb) infection and support bacterial persistence. Human TB granulomas are enriched for immunosuppressive factors typically associated with tumor-immune evasion, raising the possibility that they promote tolerance to infection. Here we identify candidate drivers for establishing this tolerogenic niche and show that the magnitude of this response correlates with bacterial persistence. We conducted a multimodal spatial analysis of 52 granulomas from 16 nonhuman primates infected with low-dose Mtb for 9-12 weeks. Each granuloma's bacterial burden was quantified individually, enabling us to assess how granuloma spatial structure and function relate to infection control. We found that a universal feature of TB granulomas is partitioning of the myeloid core into two distinct metabolic environments, one of which is hypoxic. This hypoxic environment is associated with pathological immune cell states, dysfunctional cellular organization of the granuloma, and a near-complete blockade of lymphocyte infiltration that would be required for a successful host response. The extent of these hypoxia-associated features correlates with higher bacterial burden. We conclude that hypoxia correlates with immune cell state and organization within granulomas and might subvert immunity to TB.

Indexed as

GranulomaMycobacterium tuberculosisTuberculosisAnimalsBacterial LoadDisease Models, AnimalHumans

Identifiers

PMID41731147
PMCPMC13361869

What Socratic holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.